|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.805
|
|
|
|
regulation of eosinophil activation
|
GO:1902566 |
2 |
0.805
|
|
|
|
negative regulation of b cell receptor signaling pathway
|
GO:0050859 |
2 |
0.799
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.760
|
Human |
|
|
osteoclast differentiation
|
GO:0030316 |
21 |
0.712
|
Human |
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.607
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.574
|
Human |
|
|
mapk cascade
|
GO:0000165 |
288 |
0.537
|
|
|
|
regulation of leukocyte migration
|
GO:0002685 |
63 |
0.525
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.522
|
Human |
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.520
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.426
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.417
|
Human |
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.403
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.401
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.399
|
Human |
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.393
|
Human |
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
0.388
|
Human |
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.384
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.382
|
Human |
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.374
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.369
|
Human |
|
|
negative regulation of regulated secretory pathway
|
GO:1903306 |
1 |
0.350
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.346
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.345
|
Human |
|
|
interleukin 8 mediated signaling pathway
|
GO:0038112 |
2 |
0.342
|
|
|
|
chemokine c c motif ligand 11 production
|
GO:0071954 |
1 |
0.341
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.340
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.338
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.313
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.309
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.308
|
Human |
|
|
cation transport
|
GO:0006812 |
331 |
0.307
|
Human |
|
|
innate immune response
|
GO:0045087 |
178 |
0.305
|
Human |
|
|
leukocyte chemotaxis
|
GO:0030595 |
76 |
0.298
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
62 |
0.295
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.292
|
Human |
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.287
|
Human |
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.279
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.266
|
Human |
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.262
|
|
|
|
negative regulation of leukocyte activation
|
GO:0002695 |
26 |
0.259
|
Human |
|
|
defense response
|
GO:0006952 |
315 |
0.259
|
Human |
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.258
|
Human |
|
|
response to other organism
|
GO:0051707 |
261 |
0.251
|
Human |
|
|
cell activation
|
GO:0001775 |
213 |
0.251
|
Human |
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.243
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.241
|
Human |
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
38 |
0.240
|
Human |
|
|
immune response inhibiting cell surface receptor signaling pathway
|
GO:0002767 |
4 |
0.237
|
Human |
|
|
activation of immune response
|
GO:0002253 |
114 |
0.236
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.235
|
Human |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.224
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.223
|
|
|
|
negative regulation of eosinophil activation
|
GO:1902567 |
1 |
0.220
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.217
|
|
|
|
astrocyte chemotaxis
|
GO:0035700 |
1 |
0.217
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.212
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.210
|
Human |
|
|
adaptive immune response
|
GO:0002250 |
49 |
0.209
|
Human |
|
|
positive regulation of behavior
|
GO:0048520 |
60 |
0.206
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.206
|
|
|
|
chemokine c c motif ligand 21 signaling pathway
|
GO:0038116 |
1 |
0.198
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
37 |
0.197
|
Human |
|
|
membrane organization
|
GO:0061024 |
292 |
0.197
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.197
|
Human |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.196
|
Human |
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.189
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.189
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.185
|
Human |
|
|
positive regulation of astrocyte chemotaxis
|
GO:2000464 |
1 |
0.182
|
|
|
|
regulation of b cell receptor signaling pathway
|
GO:0050855 |
4 |
0.182
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.179
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.178
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.175
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.172
|
Human |
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
33 |
0.171
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
45 |
0.171
|
Human |
|
|
negative regulation of t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell
|
GO:2001189 |
1 |
0.167
|
Human |
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.166
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.162
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.158
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.156
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.156
|
Human |
|
|
regulation of humoral immune response mediated by circulating immunoglobulin
|
GO:0002923 |
3 |
0.156
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.151
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
43 |
0.150
|
Human |
|
|
angiogenesis
|
GO:0001525 |
147 |
0.148
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.145
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.145
|
Human |
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.145
|
Human |
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
29 |
0.145
|
Human |
|
|
calcium mediated signaling
|
GO:0019722 |
44 |
0.141
|
|
|
|
positive regulation of regulatory t cell differentiation
|
GO:0045591 |
3 |
0.141
|
Human |
|
|
inflammatory response
|
GO:0006954 |
79 |
0.140
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.140
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.140
|
Human |
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.139
|
Human |
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.137
|
Human |
|
|
negative regulation of interleukin 12 secretion
|
GO:2001183 |
1 |
0.135
|
Human |
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.135
|
Human |
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.130
|
Human |
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.128
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.127
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.125
|
Human |
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.124
|
Human |
|
|
immune response in mucosal associated lymphoid tissue
|
GO:0002386 |
1 |
0.123
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
33 |
0.122
|
Human |
|
|
negative regulation of activation of jak2 kinase activity
|
GO:1902569 |
1 |
0.121
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.120
|
Human |
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
33 |
0.120
|
Human |
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.120
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.119
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.118
|
Human |
|
|
metal ion transport
|
GO:0030001 |
272 |
0.115
|
Human |
|
|
myeloid leukocyte activation
|
GO:0002274 |
34 |
0.115
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.115
|
|
|
|
positive regulation of leukocyte chemotaxis
|
GO:0002690 |
38 |
0.113
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
10 |
0.112
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.112
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.111
|
Human |
|
|
platelet formation
|
GO:0030220 |
4 |
0.111
|
|
|
|
regulation of tumor necrosis factor biosynthetic process
|
GO:0042534 |
8 |
0.109
|
Human |
|
|
negative regulation of alpha beta t cell activation
|
GO:0046636 |
3 |
0.109
|
Human |
|
|
positive regulation of chemotaxis
|
GO:0050921 |
57 |
0.108
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.108
|
Human |
|
|
positive regulation of immune effector process
|
GO:0002699 |
40 |
0.107
|
Human |
|
|
protein secretion
|
GO:0009306 |
98 |
0.106
|
Human |
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.105
|
Human |
|
|
chemokine c c motif ligand 19 signaling pathway
|
GO:0038115 |
1 |
0.104
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.104
|
Human |
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.103
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.103
|
Human |
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.103
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.102
|
Human |
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.101
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
15 |
0.100
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
14 |
0.100
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.099
|
|
|
|
granulocyte migration
|
GO:0097530 |
40 |
0.098
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.098
|
Human |
|
|
gamma delta t cell activation
|
GO:0046629 |
3 |
0.098
|
Human |
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.097
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
4 |
0.096
|
|
|
|
phagocytosis recognition
|
GO:0006910 |
3 |
0.096
|
|
|
|
negative regulation of leukocyte degranulation
|
GO:0043301 |
1 |
0.095
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.095
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
51 |
0.095
|
Human |
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.094
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.094
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.093
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.090
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.090
|
|
|
|
regulation of astrocyte chemotaxis
|
GO:2000458 |
1 |
0.090
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.088
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.087
|
Human |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.087
|
Human |
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
13 |
0.087
|
Human |
|
|
regulation of regulatory t cell differentiation
|
GO:0045589 |
4 |
0.085
|
Human |
|
|
blood vessel development
|
GO:0001568 |
172 |
0.082
|
|
|
|
immunoglobulin transcytosis in epithelial cells
|
GO:0002414 |
1 |
0.082
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.082
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
46 |
0.082
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.081
|
Human |
|
|
endocytosis
|
GO:0006897 |
159 |
0.081
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.080
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.080
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.079
|
Human |
|
|
system process
|
GO:0003008 |
349 |
0.079
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.079
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.078
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.076
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.076
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.076
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
72 |
0.075
|
Human |
|
|
negative regulation of nk t cell activation
|
GO:0051134 |
1 |
0.075
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.074
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.073
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.073
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.073
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.072
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.072
|
|
|
|
cellular defense response
|
GO:0006968 |
2 |
0.071
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.071
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.071
|
|
|
|
eosinophil activation
|
GO:0043307 |
3 |
0.071
|
|
|
|
regulation of leukocyte chemotaxis
|
GO:0002688 |
46 |
0.070
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.069
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
37 |
0.069
|
Human |
|
|
regulation of interleukin 12 secretion
|
GO:2001182 |
1 |
0.069
|
Human |
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.069
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.068
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.067
|
Human |
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.067
|
Human |
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.067
|
Human |
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.067
|
Human |
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.067
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.067
|
|
|
|
negative regulation of leukocyte apoptotic process
|
GO:2000107 |
16 |
0.067
|
Human |
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.066
|
Human |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.066
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.066
|
Human |
|
|
maintenance of location
|
GO:0051235 |
112 |
0.066
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.065
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.065
|
Human |
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.065
|
|
|
|
positive regulation of cytolysis
|
GO:0045919 |
3 |
0.064
|
Human |
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.064
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.064
|
Human |
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.063
|
|
|
|
phagocytosis engulfment
|
GO:0006911 |
7 |
0.063
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.063
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.063
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.063
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.062
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.062
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.062
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
41 |
0.061
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.061
|
Human |
|
|
negative regulation of immune effector process
|
GO:0002698 |
38 |
0.061
|
Human |
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.060
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.059
|
Human |
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
45 |
0.059
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.059
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.059
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.058
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
2 |
0.058
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.058
|
Human |
|
|
cell adhesion
|
GO:0007155 |
325 |
0.057
|
Human |
|
|
vasculature development
|
GO:0001944 |
181 |
0.057
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.057
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.056
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
25 |
0.056
|
Human |
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.056
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.056
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.055
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.055
|
Human |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.055
|
|
|
|
regulation of t cell receptor signaling pathway
|
GO:0050856 |
7 |
0.055
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.055
|
|
|
|
neutrophil migration
|
GO:1990266 |
25 |
0.054
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.053
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
55 |
0.053
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.053
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.053
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.052
|
|
|
|
regulation of nk t cell activation
|
GO:0051133 |
4 |
0.052
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.052
|
Human |
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.052
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.051
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
74 |
0.051
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.051
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.051
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
51 |
0.051
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
2 |
0.051
|
Human |
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.050
|
Human |
|
|
positive regulation of leukocyte migration
|
GO:0002687 |
46 |
0.050
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.050
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.050
|
Human |
|
|
immune system development
|
GO:0002520 |
195 |
0.050
|
Human |
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.050
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.050
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.049
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.049
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.049
|
|
|
|
chemokine production
|
GO:0032602 |
32 |
0.049
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.049
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.049
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
22 |
0.048
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.048
|
|
|
|
nk t cell activation
|
GO:0051132 |
4 |
0.048
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
63 |
0.048
|
|
|
|
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002823 |
8 |
0.048
|
Human |
|
|
positive regulation of neutrophil migration
|
GO:1902624 |
7 |
0.047
|
|
|
|
monocyte chemotaxis
|
GO:0002548 |
20 |
0.047
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.047
|
Human |
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.047
|
|
|
|
fc receptor signaling pathway
|
GO:0038093 |
2 |
0.047
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.047
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.047
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.046
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.046
|
Human |
|
|
regulation of exocytosis
|
GO:0017157 |
46 |
0.046
|
|
|
|
myeloid dendritic cell chemotaxis
|
GO:0002408 |
3 |
0.046
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.045
|
Human |
|
|
oogenesis
|
GO:0048477 |
2 |
0.045
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.045
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.045
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.045
|
Human |
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.045
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.044
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.043
|
Human |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.043
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.043
|
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.042
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.042
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.042
|
|
|
|
negative regulation of tumor necrosis factor biosynthetic process
|
GO:0042536 |
3 |
0.042
|
Human |
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.042
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
54 |
0.041
|
Human |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.041
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.041
|
|
|
|
cellular response to interleukin 15
|
GO:0071350 |
6 |
0.041
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.041
|
Human |
|
|
negative regulation of interleukin 10 production
|
GO:0032693 |
7 |
0.040
|
Human |
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
15 |
0.040
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
1 |
0.040
|
Human |
|
|
interleukin 12 secretion
|
GO:0072610 |
1 |
0.040
|
Human |
|
|
regulation of release of sequestered calcium ion into cytosol
|
GO:0051279 |
27 |
0.040
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.040
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.040
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.039
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.039
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.039
|
|
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
3 |
0.039
|
|
|
|
negative regulation of immune response
|
GO:0050777 |
40 |
0.038
|
Human |
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.038
|
|
|
|
head development
|
GO:0060322 |
108 |
0.038
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.038
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
23 |
0.038
|
Human |
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.038
|
|
|
|
negative regulation of t cell receptor signaling pathway
|
GO:0050860 |
4 |
0.038
|
|
|
|
interferon beta secretion
|
GO:0035546 |
1 |
0.038
|
Human |
|
|
regulation of dendritic cell apoptotic process
|
GO:2000668 |
4 |
0.037
|
Human |
|
|
regulation of interferon beta secretion
|
GO:0035547 |
1 |
0.037
|
Human |
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.037
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.037
|
|
|
|
negative regulation of phagocytosis engulfment
|
GO:0060101 |
1 |
0.037
|
|
|
|
negative regulation of interleukin 10 secretion
|
GO:2001180 |
1 |
0.037
|
Human |
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.037
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.036
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
11 |
0.036
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.036
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.036
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.036
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.036
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.036
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.035
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.035
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.035
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.035
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
46 |
0.035
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.034
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
56 |
0.034
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.034
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.034
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.034
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
4 |
0.034
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.034
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.034
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.034
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.034
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.034
|
|
|
|
activation of mapk activity
|
GO:0000187 |
45 |
0.033
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.033
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.033
|
|
|
|
cellular extravasation
|
GO:0045123 |
21 |
0.033
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.033
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
48 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.033
|
Human |
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.033
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.032
|
Human |
|
|
immune effector process
|
GO:0002252 |
159 |
0.032
|
Human |
|
|
secretion
|
GO:0046903 |
254 |
0.032
|
Human |
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.032
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.032
|
Human |
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.032
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.032
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.032
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
35 |
0.031
|
Human |
|
|
chemotaxis
|
GO:0006935 |
157 |
0.031
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
62 |
0.031
|
Human |
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.031
|
|
|
|
negative regulation of myeloid cell apoptotic process
|
GO:0033033 |
4 |
0.031
|
|
|
|
negative regulation of mononuclear cell proliferation
|
GO:0032945 |
15 |
0.031
|
Human |
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.031
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.031
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.031
|
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.031
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.031
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.031
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.031
|
Human |
|
|
positive regulation of neutrophil chemotaxis
|
GO:0090023 |
7 |
0.030
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.030
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.030
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.030
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.030
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.030
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.030
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.030
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.030
|
Human |
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.030
|
|
|
|
positive regulation of glucose import in response to insulin stimulus
|
GO:2001275 |
3 |
0.030
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.030
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.030
|
|
|
|
regulation of natural killer cell mediated cytotoxicity
|
GO:0042269 |
16 |
0.030
|
Human |
|
|
positive regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031666 |
4 |
0.029
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.029
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.029
|
|
|
|
negative regulation of myeloid leukocyte mediated immunity
|
GO:0002887 |
1 |
0.029
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
43 |
0.029
|
Human |
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.029
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
41 |
0.029
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.028
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.028
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
23 |
0.028
|
Human |
|
|
negative regulation of eosinophil migration
|
GO:2000417 |
2 |
0.028
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.028
|
|
|
|
granulocyte activation
|
GO:0036230 |
10 |
0.028
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.027
|
|
|
|
cd8 positive alpha beta t cell activation
|
GO:0036037 |
3 |
0.027
|
Human |
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.027
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.027
|
Human |
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.027
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
48 |
0.027
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.026
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.026
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.026
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.026
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.026
|
|
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
2 |
0.026
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
42 |
0.026
|
Human |
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.026
|
Human |
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.025
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.025
|
|
|
|
complement receptor mediated signaling pathway
|
GO:0002430 |
3 |
0.025
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.025
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.025
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.025
|
Human |
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.025
|
Human |
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.025
|
|
|
|
neutrophil activation
|
GO:0042119 |
9 |
0.025
|
|
|
|
serotonin secretion
|
GO:0001820 |
1 |
0.025
|
Human |
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.025
|
Human |
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
24 |
0.025
|
Human |
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.025
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.025
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
58 |
0.025
|
Human |
|
|
regulation of gamma delta t cell activation involved in immune response
|
GO:2001191 |
1 |
0.025
|
Human |
|
|
endothelial cell proliferation
|
GO:0001935 |
65 |
0.025
|
|
|
|
memory
|
GO:0007613 |
3 |
0.024
|
|
|
|
negative regulation of mast cell activation involved in immune response
|
GO:0033007 |
1 |
0.024
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.024
|
|
|
|
carbohydrate transport
|
GO:0008643 |
37 |
0.024
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
41 |
0.024
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.024
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.024
|
|
|
|
regulation of neutrophil chemotaxis
|
GO:0090022 |
10 |
0.024
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
37 |
0.024
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.023
|
Human |
|
|
protein polymerization
|
GO:0051258 |
71 |
0.023
|
|
|
|
negative regulation of immunoglobulin mediated immune response
|
GO:0002890 |
3 |
0.023
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.023
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.023
|
|
|
|
jnk cascade
|
GO:0007254 |
80 |
0.022
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.022
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
55 |
0.022
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.022
|
Human |
|
|
azole transport
|
GO:0045117 |
4 |
0.022
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.022
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
27 |
0.022
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.022
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.022
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.022
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.021
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.021
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.021
|
|
|
|
platelet aggregation
|
GO:0070527 |
32 |
0.021
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
35 |
0.021
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.021
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.021
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.021
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.021
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.021
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
26 |
0.021
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
4 |
0.021
|
|
|
|
serotonin transport
|
GO:0006837 |
3 |
0.021
|
Human |
|
|
glomerulus development
|
GO:0032835 |
15 |
0.021
|
|
|
|
b cell proliferation
|
GO:0042100 |
22 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.021
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.021
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
18 |
0.021
|
Human |
|
|
neutrophil chemotaxis
|
GO:0030593 |
24 |
0.021
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.020
|
|
|
|
camp metabolic process
|
GO:0046058 |
61 |
0.020
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.020
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.020
|
|
|
|
phagocytosis
|
GO:0006909 |
42 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.020
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.020
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.020
|
|
